A novel bradykinin potentiating peptide isolated from Bothrops jararacussu venom using catallytically inactive oligopeptidase EP24.15

FEBS Journal

Volumn 275, Issue 10, 2008, Pages 2442-2454

  Rioli, Vanessa ^a   Prezoto, Benedito C ^a   Konno, Katsuhiro ^a   Melo, Robson L ^a   Klitzke, Clécio F ^a   Ferro, Emer S ^b   Ferreira Lopes, Mônica ^a   Camargo, Antonio C M ^a   Portaro, Fernanda C V ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin converting enzyme; Blood pressure; Bradykinin potentiating peptide; Snake venom; Thimet oligopeptidase

Indexed keywords

AMINO ACID; BATROXOBIN; BRADYKININ; GLUTAMYLALANYLARGINYLPROLYLPROLYLHISTIDYLPROLYLPROLYLISOLEUCYLPROLYLPROLINE; GLUTAMYLALANYLARGINYLPROLYLPROLYLHISTIDYLPROLYLPROLYLISOLEUCYLPROLYLPROLYLALANYLPROLINE; GLUTAMYLASPARAGINYLTRYPTOPHANYLPROLYLHISTIDYLPROLYLGLUTAMINYLISOLEUCYLPROLYLPROLINE; GLUTAMYLGLYCYLGLYCYLTRYPTOPHANYLPROLYLARGINYLPROLYLGLYCYLPROLYLGLUTAMYLISOLEUCYLPROLYLPROLINE; MUTANT PROTEIN; OLIGOPEPTIDE; PEPTIDASE;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ARTERIOLE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CATALYSIS; CONTROLLED STUDY; CREMASTER MUSCLE; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENTIATION; ENZYME INACTIVATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; MALE; MASS SPECTROMETRY; MICROCIRCULATION; MICROSCOPY; MOUSE; MUSCLE BLOOD FLOW; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; RAT; SKIN BLOOD FLOW; VASODILATATION; VENULE;

AMINO ACID SEQUENCE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; BOTHROPS; BRADYKININ; CROTALID VENOMS; ENDOPEPTIDASES; HUMANS; MALE; MICROCIRCULATION; MOLECULAR SEQUENCE DATA; MOLECULAR WEIGHT; PEPTIDES; PROTEIN PRECURSORS; RATS; RATS, WISTAR; SEQUENCE ALIGNMENT;

BOTHROPS JARARACUSSU;

EID: 42649139899     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/j.1742-4658.2008.06389.x     Document Type: Article

References (59)

1. Ferreira SH Rocha e Silva M (1965) Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom. Experientia 21, 347 349.
2. Ferreira SH, Bartelt DC Greene LJ (1970) Isolation of bradykinin potentiating peptides from Bothrops jararaca venom. Biochemistry 9, 2583 2593.
3. Ondetti MA, Williams NJ, Sabo EF, Pluscec J, Weaver ER Kocy O (1971) Angiotensin-converting enzyme inhibitors from the venom of Bothrops jararaca. Isolation, elucidation of structure and synthesis. Biochemistry 10, 4033 4039.
4. Ondetti MA, Rubin B Cushman DW (1977) Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science 196, 441 444.
5. Skeggs LT, Kahn JR Shumway NP (1956) The preparation and function of the hypertensin-converting enzyme. J Exp Med 103, 295 299.
6. Yang HYT, Erdös EG Levin Y (1970) A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin. Biochim Biophys Acta 214, 374 376.
7. Linz W, Wiemer G, Gohlke P, Unger T Scholkens BA (1995) Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors. Pharmacol Rev 47, 25 49.
8. Ondetti MA Cushman DW (1982) Enzymes of the renin-angiotensin system and their inhibitors. Annu Rev Biochem 51, 283 308.
9. Collier JG, Robinson BF Vane JR (1973) Reduction of pressor effects of angiotensin I in man by synthetic nonapeptide (B.P.P. 9a or SQ 20,881) which inhibits converting enzyme. Lancet i, 72 74.
10. Johnson JG, Black WD, Vukovich RA, Hatch FE Jr., Friedman BI, Blackwell CF, Shenouda AN, Share L, Shade RE, Acchiardo SR et al. (1975) Treatment of patients with severe hypertension by inhibition of angiotensin-converting enzyme. Clin Sci Mol Med 48, 53S 56S.
11. Gavras H, Brunner HR, Laragh JH, Gavras I Vukovich RA (1975) The use of angiotensin-converting enzyme inhibitor in the diagnosis and treatment of hypertension. Clin Sci Mol Med 48, 57S 60S.
12. Kato H Suzuki T (1971) Bradykinin potentiating peptides from the venom of Agkistrodon halys blomhoffii. Isolation of five bradykinin potentiators and the amino acid sequences of two of them, potentiators B and C. Biochemistry 10, 972 980.
13. Kato H, Suzuki T, Okada K, Kimura T Sakakibara S (1973) Structure of potentiator A, one of the five bradykinin potentiating peptides from the venom of Agkistrodon halys blomhoffii. Experientia 29, 574 575.
14. Cintra AC, Vieira CA Giglio JR (1990) Primary structure and biological activity of bradykinin potentiating peptides from Bothrops insularis snake venom. J Protein Chem 9, 221 227.
15. Ferreira LAF, Henriques OB, Lebrun I, Batista MBC, Prezoto BC, Andreoni ASS, Zelnik R Habermehl G (1992) A new bradykinin potentiating peptide (peptide P) isolated from the venom of Bothrops jararacussu (jararacuçu tapete, urutu dourado). Toxicon 30, 33 40.
16. Ferreira LAF, MoÈllring T, Lebrun FLAS, Raida M, Znottka R Habermehl GG (1995) Structure and effects of a kinin potentiating fraction F (AppF) isolated from Agkistrodon piscivorus piscivorus venom. Toxicon 33, 1313 1319.
17. Ferreira LA, Galle A, Raida M, Schraderr M, Lebrun I Habermehl G (1998) Isolation: analysis and properties of three bradykinin potentiating peptides (BPP-II, BPP-III, and BPP-V) from Bothrops neuwiedi venom. J Protein Chem 17, 285 289.
18. Higuchi S, Murayama N, Saguchi K, Ohi H, Fujita Y, Camargo AC, Ogawa T, Deshimaru M Ohno M (1999) Bradykinin potentiating peptides and C-type natriuretic peptides from snake venom. Immunopharmacology 44, 129 135.
19. Ianzer D, Konno K, Marques-Porto R, Vieira Portaro FC, Stöcklin R, Martins de Camargo AC Pimenta DC (2004) Identification of five new bradykinin potentiating peptides (BPPs) from Bothrops jararaca crude venom by using electrospray ionization tandem mass spectrometry after a two-step liquid chromatography. Peptides 25, 1085 1092.
20. Sosnina NAA, Golubenco Z, Akhunov AA, Kugaevskaya EV, Eliseeva YE Orekhovich VN (1990) Bradykinin potentiating peptides from the spider Latrodectus tredecimguttatus inhibitors of carboxycathepsin and of a preparation of karakurt venom kininase. Dokl Akad Nauk SSSR 315, 281 284.
21. Ferreira LA, Alves EW Henriques OB (1993) Peptide T, a novel bradykinin potentiator isolated from Tityus serrulatus scorpion venom. Toxicon 8, 941 947.
22. Yamafuji K, Taniguchi Y Sakamoto E (1996) The thiol enzyme from rat spleen that produces bradykinin potentiating peptide from rat plasma. Immunopharmacology 32, 157 159.
23. Piot JM, Zhao Q, Guillochon D, Ricart G Thomas D (1992) Isolation and characterization of a bradykinin potentiating peptide from a bovine peptic hemoglobin hydrolysate. FEBS Lett 299, 75 79.
24. Zhao Q, Garreau I, Sannier F Piot JM (1997) Opioid peptides derived from hemoglobin: hemorphins. Biopolymers 43, 75 98.
25. Henriques OB, de Deus RB Santos RA (1987) Bradykinin potentiating peptides isolated from alpha-casein tryptic hydrolysate. Biochem Pharmacol 36, 182 184.
26. Lebrun I, Lebrun FL, Henriques OB, Carmona AK, Juliano L Camargo AC (1995) Isolation and characterization of a new bradykinin potentiating octapeptide from gamma-casein. Can J Physiol Pharmacol 73, 85 91.
27. Matsui T, Li CH Osajima Y (1999) Preparation and characterization of novel bioactive peptides responsible for angiotensin I-converting enzyme inhibition from wheat germ. J Peptide Sci 5, 289 297.
28. Cotton J, Hayashi MAF, Cuniasse P, Vazeux G, Ianzer D, Camargo ACM Dive V (2002) Selective inhibition of the C-domain of angiotensin I converting enzyme by bradykinin potentiating peptides. Biochemistry 41, 6065 6071.
29. Hayashi MA, Murbach AF, Ianzer D, Portaro FC, Prezoto BC, Fernandes BL, Silveira PF, Silva CA, Pires RS, Britto LRG et al. (2003) The C-type natriuretic peptide precursor of snake brain contains highly specific inhibitors of the angiotensin-converting enzyme. J Neurochem 85, 969 977.
30. Murayama N, Hayashi MA, Ohi H, Ferreira LA, Fernandes BL, Yamane T Camargo ACM (1997) Cloning and sequence analysis of a Bothrops jararaca cDNA encoding a precursor of seven bradykinin potentiating peptides and a C-type natriuretic peptide. Proc Natl Acad Sci USA 94, 1189 1193.
31. Watt PM (2006) Screening for peptide drugs from the natural repertoire of biodiverse protein folds. Nat Biotechnol 24, 177 183.
32. Rioli V, Gozzo FC, Heimann AS, Linardi A, Krieger JE, Shida CS, Almeida PC, Hyslop S, Eberlin MN Ferro ES (2003) Novel natural peptide substrates for endopeptidases 24.15, neurolysin, and angiotensin-converting enzyme. J Biol Chem 278, 8547 8555.
33. Blais PA, Côté J, Morin J, Larouche A, Gendron G, Fortier A, Regoli D, Neugebauer W Gobeil F Jr. (2005) Hypotensive effects of hemopressin and bradykinin in rabbits, rats and mice. A comparative study. Peptides 26, 1317 1322.
34. Lippton H, Lin B, Gumusel B, Witriol N, Wasserman A Knight M (2006) Hemopressin, a hemoglobin fragment, dilates the rat systemic vascular bed through release of nitric oxide. Peptides 27, 2284 2288.
35. Dale CS, Pagano R de L, Rioli V, Hyslop S, Giorgi R Ferro ES (2005) Antinociceptive action of hemopressin in experimental hyperalgesia. Peptides 26, 431 436.
36. Turner AJ, Matsas R Kenny AJ (1985) Are there neuropeptide-specific peptidases? Biochem Pharmacol 34, 1347 1356.
37. Rioli V, Kato A, Portaro FC, Cury GK, te Kaat K, Vincent B, Checler F, Camargo AC, Glucksman MJ, Roberts JL et al. (1998) Neuropeptide specificity and inhibition of recombinant isoforms of the endopeptidase 3.4.24.16 family: comparison with the related recombinant endopeptidase 3.4.24.15. Biochem Biophys Res Commun 250, 5 11.
38. Natesh R, Schwager SLU, Sturrock ED Acharya KR (2003) Crystal structure of the human angiotensin-converting enzyme-lisinopril complex. Nature 421, 551 554.
39. Skidgel RA Erdos EG (1989) Angiotensin I converting enzyme. Adv Exp Med Biol 247A, 25 28.
40. Ehlers MR Riordan JF (1989) Angiotensin-converting enzyme: new concepts concerning its biological role. Biochemistry 27, 5311 5318.
41. Rocha e Silva M, Beraldo WT Rosenfeld G (1949) Bradykinin, a hypotensive and a smooth muscle stimulating factor released from plasma globulin by snake venom and by trypsin. Am J Physiol 156, 261 270.
42. Ondetti MA Cushman DW (1981) Inhibitors of angiotensin converting enzyme. In Biochemical Regulation of Blood Pressure (Soffer RL, ed pp. 165 204. John Wiley, New York, NY.
43. Wermelinger LS, Dutra DL, Oliveira-Carvalho AL, Soares MR, Bloch C Jr. Zingali RB (2005) Fast analysis of low molecular mass compounds present in snake venom: identification of ten new pyroglutamate-containing peptides. Rapid Commun Mass Spectrom 19, 1703 1708.
44. Pimenta DC, Prezoto BC, Konno K, Melo RL, Furtado MF, Camargo AC Serrano SM (2007) Mass spectrometric analysis of the individual variability of Bothrops jararaca venom peptide fraction. Evidence for sex-based variation among the bradykinin potentiating peptides. Rapid Commun Mass Spectrom 21, 1034 1042.
45. Gomes CL, Konno K, Conceição IM, Ianzer D, Yamanouye N, Prezoto BC, Assakura MT, Rádis-Baptista G, Yamane T, Santos RA et al. (2007) Identification of novel bradykinin potentiating peptides (BPPs) in the venom gland of a rattlesnake allowed the evaluation of the structure-function relationship of BPPs. Biochem Pharmacol 74, 1350 1360.
46. Oliveira EB, Martins AR Camargo ACM (1976) Isolation of brain endopeptidases: influence of the size and sequence of substrates structurally related to bradykinin. Biochemistry 15, 1967 1974.
47. Oliveira V, Campos M, Melo RL, Ferro ES, Camargo AC, Juliano MA Juliano L (2001) Substrate specificity characterization of recombinant metallo oligo-peptidases thimet oligopeptidase and neurolysin. Biochemistry 40, 4417 4425.
48. Camargo ACM, Reis ML Caldo H (1979) Susceptibility of a peptide derived from bradykinin to hydrolysis by brain endo-oligopeptidases and pancreatic proteinases. J Biol Chem 254, 5304 5307.
49. Camargo AC, Gomes MD, Reichl AP, Ferro ES, Jacchieri S, Hirata IY Juliano L (1997) Structural features that make oligopeptides susceptible substrates for hydrolysis by recombinant thimet oligopeptidase. Biochem J 324, 517 522.
50. Montiel JL, Cornille F, Roques BP Noble F (1997) Nociceptin/orphanin FQ metabolism: role of aminopeptidase and endopeptidase 24.15. J Neurochem 68, 354 361.
51. Giles AR (1987) Guidelines for the use of animals in biochemical research. Thromb Haemost 58, 1078 1084.
52. Thompson JD, Higgins DG Gibson TJ (1994) CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, positions-specific gap penalties and weight matrix choice. Nucleic Acids Res 22, 4673 4680.
53. Shrimpton CN, Glucksman MJ, Lew RA, Tullai JW, Margulies EH, Roberts JL Smith AI (1997) Thiol activation of endopeptidase EC 3.4.24.15. A novel mechanism for the regulation of catalytic activity. J Biol Chem 272, 17395 17399.
54. Tullai JW, Cummins PM, Pabon A, Roberts JL, Lopingco MC, Shrimpton CN, Smith AI, Martignetti JA, Ferro ES Glucksman MJ (2000) The neuropeptide processing enzyme EC 3.4.24.15 is modulated by protein kinase A phosphorylation. J Biol Chem 275, 36514 36522.
55. Araujo MC, Melo RI, Del Nery E, Alves MF, Juliano MA, Casarini DE, Juliano L Carmona AK (1999) Internally quenched fluorogenic substrates for angiotensin I-converting enzyme. J Hypertens 17, 665 672.
56. Nicklin MJ Barret AJ (1984) Inhibition of cysteine proteinases and dipeptidyl peptidase I by egg-white cystatin. Biochem J 223, 245 253.
57. Baez S (1973) An open cremaster muscle preparation for the study of blood vessels by in vivo microscopy. Microvasc Res 5, 384 394.
58. Lomonte B, Lundgren J, Johansson B Bagge U (1994) The dynamics of local tissue damage induced by Bothrops asper snake venom and myotoxin II on the mouse cremaster muscle: an intravital and electron microscopic study. Toxicon 32, 41 55.
59. Shigematsu S, Ishida S, Gute DC Korthuis RJ (1999) Bradykinin prevents postischemic leukocyte adhesion and emigration and attenuates microvascular barrier disruption. Am J Physiol 277, H161 H171.